Patents by Inventor Timo Gemoll

Timo Gemoll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Platelet biomarkers in cancer diagnosis
    Patent number: 10054596
    Abstract: The present embodiments relate generally to the field of cancer diagnostics. More specifically the embodiments relate to platelet derived biomarkers used for diagnosis of cancer or cancer progression, as well as prognosis and improved treatment.
    Type: Grant
    Filed: January 22, 2014
    Date of Patent: August 21, 2018
    Assignee: NEOPROTEOMICS AB
    Inventors: Bo Franzèn, Gert Auer, Susanne Becker, Marta Lomnytska, Timo Gemoll, Jens Habermann
  • PLATELET BIOMARKERS IN CANCER DIAGNOSIS
    Publication number: 20150369817
    Abstract: The present embodiments relate generally to the field of cancer diagnostics. More specifically the embodiments relate to platelet derived biomarkers used for diagnosis of cancer or cancer progression, as well as prognosis and improved treatment.
    Type: Application
    Filed: January 22, 2014
    Publication date: December 24, 2015
    Inventors: Bo FRANZÈN, Gert AUER, Susanne BECKER, Marta LOMNYTSKA, Timo GEMOLL, Jens HABERMANN
  • DIFFERENTIAL DIAGNOSIS OF PANCREATIC ADENOMAS
    Publication number: 20130196876
    Abstract: The invention relates to a method for the diagnosis of pancreatic adenomas, to biomarkers for use in said method, to kits for carrying out the method, and to the use of said method for detecting pancreatic adenomas. The following markets are used: KCNABT, CIORF77, SPSB2, MED9, STK40, ITGB3BP, SCEL, PDPK1, DUSP15, MED19, NAP1L3, TMOD3, CSPP1, TMOD2, INPP5A and IGHG.
    Type: Application
    Filed: September 28, 2011
    Publication date: August 1, 2013
    Applicant: UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN
    Inventors: Jens Habermann, Timo Gemoll, Uwe Johannes Roblick